Results 201 to 210 of about 112,461 (257)
Inflammatory macrophages drive smooth muscle dedifferentiation via YAP signaling in murine deep vein thrombosis. [PDF]
Yang H, Zhou T, Kim J, Liu B.
europepmc +1 more source
Behçet's Disease as a Cause of Recurrent Deep Vein Thrombosis. [PDF]
Rehman A, Monks W, Ahmed R, Marchbank N.
europepmc +1 more source
Prevalence and risk of deep vein thrombosis recurrence in Thai patients with iliac compression syndrome. [PDF]
Chonwarangkoon H +8 more
europepmc +1 more source
Midterm clinical outcomes of mechanical versus rheolytic thrombectomy for iliofemoral or iliocaval deep vein thrombosis. [PDF]
Forgo G +7 more
europepmc +1 more source
Deep Vein Thrombosis Prevention in Acute Ischemic Stroke Patients with Lower Limb Paralysis: A Narrative Review. [PDF]
Peng J, Long S, Feng L.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Lancet, The, 2005
Deep vein thrombosis and its sequelae pulmonary embolism and post-thrombotic syndrome are some of the most common disorders. A thrombus either arises spontaneously or is caused by clinical conditions including surgery, trauma, or prolonged bed rest. In these instances, prophylaxis with low-dose anticoagulation is effective.
Paul A Kyrle
exaly +3 more sources
Deep vein thrombosis and its sequelae pulmonary embolism and post-thrombotic syndrome are some of the most common disorders. A thrombus either arises spontaneously or is caused by clinical conditions including surgery, trauma, or prolonged bed rest. In these instances, prophylaxis with low-dose anticoagulation is effective.
Paul A Kyrle
exaly +3 more sources
Current Treatment Options in Cardiovascular Medicine, 1999
Initially, patients with deep vein thrombosis (DVT) should be treated with a 5- to 7-day course of heparin or low-molecular-weight heparin (LMWH). They can be administered LMWH as outpatients. Patients with extensive iliofemoral thrombosis, major pulmonary embolism, or concomitant medical illness, and those at high risk for bleeding, should be treated ...
, Al-Zahrani, , Bates, , Weitz
openaire +5 more sources
Initially, patients with deep vein thrombosis (DVT) should be treated with a 5- to 7-day course of heparin or low-molecular-weight heparin (LMWH). They can be administered LMWH as outpatients. Patients with extensive iliofemoral thrombosis, major pulmonary embolism, or concomitant medical illness, and those at high risk for bleeding, should be treated ...
, Al-Zahrani, , Bates, , Weitz
openaire +5 more sources

